Bio Protocol vs Brett (Based) — how do they compare? Bio Protocol trades at Rp433.83 (market cap Rp986,63M, Rp162,5M 24h volume), while Brett (Based) trades at Rp68.1 (market cap Rp681,75M, Rp65,75M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 10B / 10B BRETT (100%) for Brett (Based). Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Brett (Based) for 31 Days on average.
| BIO | BRETT | |
|---|---|---|
Market Cap | Rp986,63M | Rp681,75M |
Volume (24h) | Rp162,5M | Rp65,75M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 10B / 10B BRETT (100%) |
Typical Hold Time | 18 Days | 31 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
BRETT is currently trading at Rp69,836 with a market cap of Rp698.01M, showing bearish technical signals with all moving averages indicating sell pressure. The token has 100% circulating supply with average hold time of 31 days. Technical indicators show neutral oscillators but bearish ADX signals, with key support at Rp66 and resistance at Rp71.
Overall outlook remains cautious due to strong bearish technical signals and limited fundamental developments. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity and concentrated sell pressure. Investors should monitor for any ecosystem developments or exchange listings that could improve sentiment.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →BRETT is Pepe's best friend and a central cultural mascot of the Base Chain. As the Base Chain ecosystem continues to expand with various projects and applications, BRETT is able to benefit from this growth by leveraging shared resources and expertise. Its potential for adoption and community engagement is closely linked to the ongoing development of the Base Chain.
Read more on BRETT →